Cargando…

Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story

Detalles Bibliográficos
Autores principales: Barosi, Giovanni, Gale, Robert Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006303/
https://www.ncbi.nlm.nih.gov/pubmed/35240682
http://dx.doi.org/10.1182/bloodadvances.2022007230
_version_ 1784686637661290496
author Barosi, Giovanni
Gale, Robert Peter
author_facet Barosi, Giovanni
Gale, Robert Peter
author_sort Barosi, Giovanni
collection PubMed
description
format Online
Article
Text
id pubmed-9006303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-90063032022-04-13 Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story Barosi, Giovanni Gale, Robert Peter Blood Adv Commentary American Society of Hematology 2022-04-07 /pmc/articles/PMC9006303/ /pubmed/35240682 http://dx.doi.org/10.1182/bloodadvances.2022007230 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Commentary
Barosi, Giovanni
Gale, Robert Peter
Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title_full Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title_fullStr Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title_full_unstemmed Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title_short Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
title_sort does ruxolitinib really prolong survival in individuals with myelofibrosis? the never-ending story
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006303/
https://www.ncbi.nlm.nih.gov/pubmed/35240682
http://dx.doi.org/10.1182/bloodadvances.2022007230
work_keys_str_mv AT barosigiovanni doesruxolitinibreallyprolongsurvivalinindividualswithmyelofibrosistheneverendingstory
AT galerobertpeter doesruxolitinibreallyprolongsurvivalinindividualswithmyelofibrosistheneverendingstory